NCT02875743View on ClinicalTrials.gov

King's Invasive Aspergillosis Study II

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

December 7, 2016

Primary Completion Date

October 31, 2018

Study Completion Date

October 31, 2019

Conditions
Aplastic AnemiaLeukemia, Myeloid, AcuteMyelodysplastic SyndromesBone Marrow Transplantation
Interventions
DRUG

Posaconazole

Trial Locations (1)

SE5 9RS

King's College Hospital NHS Foundation Trust, London

All Listed Sponsors
lead

King's College Hospital NHS Trust

OTHER

NCT02875743 - King's Invasive Aspergillosis Study II | Biotech Hunter | Biotech Hunter